1. Introduction {#sec1-toxins-09-00318}
===============

Aflatoxins (AFs), which are highly toxic mycotoxins produced by *Aspergillus parasiticus*, *Aspergillus flavus* and *Aspergillus nomius* (rarely), present in a wide range of food and feed commodities \[[@B1-toxins-09-00318],[@B2-toxins-09-00318]\]. The exposure of aflatoxin B~1~ (AFB~1~)-contaminated feed to lactating mammals will lead to the conversion of AFB~1~ into aflatoxin M~1~ (AFM~1~) through hydroxylation under liver cytochrome P450 catalysis \[[@B3-toxins-09-00318],[@B4-toxins-09-00318]\]. AFM~1~, which have intense hepatotoxic and carcinogenic effects and have been designated as group1 carcinogen by the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO) in 2002 \[[@B5-toxins-09-00318]\], will subsequently be secreted in the milk of lactating mammals. As AFM~1~ is quite stable during general pasteurization and storage process and will not be destroyed until the temperature exceeds 299 °C, it will enter human body through milk drinking and endanger human health \[[@B6-toxins-09-00318],[@B7-toxins-09-00318]\]. Therefore, many countries have stipulated the maximum residue limit (MRL) of AFM~1~ in dairy and dairy products. In the European Community, the MRL level for the presence of AFM~1~ in milk has been set at 0.05 ng/mL \[[@B8-toxins-09-00318]\]. According to regulations of the U.S. Food and Drug Administration \[[@B9-toxins-09-00318]\] and the Chinese government \[[@B10-toxins-09-00318]\], the MRL level of AFM~1~ in milk and milk products should not exceed 0.5 ng/mL. Hence it is very important to monitor the concentration of AFM~1~ in dairy products to ensure human health and consumption safety.

In the past few years, various testing methods have been developed for AFM~1~ detection, which includes thin-layer chromatography (TLC) \[[@B11-toxins-09-00318],[@B12-toxins-09-00318]\], enzyme-linked immunosorbent assay (ELISA) \[[@B13-toxins-09-00318],[@B14-toxins-09-00318]\], high-performance liquid chromatography (HPLC) \[[@B15-toxins-09-00318],[@B16-toxins-09-00318]\], liquid chromatography-tandem mass spectrometry (LC-MS) \[[@B17-toxins-09-00318],[@B18-toxins-09-00318]\] and immunosensors \[[@B19-toxins-09-00318],[@B20-toxins-09-00318]\]. Compared with those mentioned above, the aptasensor, which exhibits unique advantages such as being less expensive, easier to operate and suitable for on-site analyses, has attracted increasing attention recently. The aptasensor is referred to as a new category of biosensor constructed with aptamers as recognition elements, which show noticeable advantages over antibodies such as small size, good reproducibility, high stability, easy chemical fabrication with signal moieties and low immunogenicity \[[@B21-toxins-09-00318]\]. Recently, Dinçkaya et al. developed an impedimetric AFM~1~ biosensor based on a 21-mer aptamer sequence for AFM~1~ and gold nanoparticles \[[@B22-toxins-09-00318]\]. Afterwards, electrochemical \[[@B23-toxins-09-00318],[@B24-toxins-09-00318]\] and fluorescent \[[@B25-toxins-09-00318]\] aptasensors have also been developed for AFM~1~ detection. Despite the achievements made in the AFM~1~ aptasensors, it is still a challenge to develop new techniques for AFM~1~ detection with improved sensitivity, simplicity and stability.

Fluorescence resonance energy transfer (FRET), which is a non-radiative energy transfer process occurring between energy donor and acceptor in close proximity (normally 1--10 nm) through long-range dipole-dipole interactions, has been widely used in quantitative determination of biomolecules \[[@B26-toxins-09-00318],[@B27-toxins-09-00318]\], small molecules \[[@B28-toxins-09-00318],[@B29-toxins-09-00318]\] and metal ions \[[@B30-toxins-09-00318],[@B31-toxins-09-00318]\] because of its homogeneous nature and high sensitivity. The fluorescence quenching ability of energy acceptors plays an important role in determining the analytical sensitivity in the FRET-based analysis. Larger palladium nanoparticles (PdNPs ≥ 30 nm), which exhibit broad and strong absorption in the whole ultraviolet-visible (UV-Vis) spectrum range with high molar extinction coefficient \[[@B32-toxins-09-00318]\], have received great attention as an energy acceptor for FRET-based biological analysis application in recent years. Additionally, an ultrasensitive biosensing platform for DNA and protein detection have been developed based on the excellent luminescence quenching ability of PdNPs towards different fluorescent dyes, such as FAM and rhodamine \[[@B32-toxins-09-00318]\].

Herein, we combined the excellent luminescence quenching ability of PdNPs towards fluorescent dyes with the highly specific binding ability of the AFM~1~ aptamer towards AFM~1~ to develop a highly sensitive PdNPs-based FRET aptasensor for AFM~1~ detection. When a FAM-labeled AFM~1~ aptamer is incubated with PdNPs, the energy donor was brought close to the energy acceptor in the range from 1 nm to 10 nm through the strong coordination interaction between the nitrogen functional groups of the AFM~1~ aptamer and PdNPs, thus resulting in the fluorescence quenching of FAM. However, after the introduction of AFM~1~ into the FRET quenching system, AFM~1~ aptamer preferentially bound with AFM~1~ accompanied with its conformational change, which greatly weakened the coordination interaction between AFM~1~ aptamer and PdNPs. Thus, the distance between FAM and PdNPs was enlarged and thereby the fluorescence recovery of FAM was observed in a AFM~1~ concentration-dependent manner. The AFM~1~ aptasensor also performed well in milk samples.

2. Results and Discussion {#sec2-toxins-09-00318}
=========================

2.1. Construction of the FRET Aptasensor for AFM~1~ {#sec2dot1-toxins-09-00318}
---------------------------------------------------

The AFM~1~ aptasensor was constructed based on aptamer-bridged FRET between FAM and PdNPs, as shown in [Scheme 1](#toxins-09-00318-sch001){ref-type="scheme"}. It has been reported that there was a strong coordination effect between nitrogen functional groups of single-stranded DNA (ssDNA) and PdNPs \[[@B32-toxins-09-00318],[@B33-toxins-09-00318]\]. However, after the hybridization between ssDNA and its complementary chains occurred, the coordination effect was greatly weakened as fewer heteroatoms were exposed to PdNPs in the double helix structure of DNA. In our design, the strong coordination effect between the 5′-FAM-labeled AFM~1~ aptamer and PdNPs brought the fluorescence donor FAM close to the fluorescence acceptor PdNPs, which resulted in the occurrence of FRET, and the fluorescence quenching of FAM was observed. After AFM~1~ was introduced into the FAM-AFM~1~ aptamer-PdNPs FRET system, AFM~1~ aptamer preferentially bound to AFM~1~ accompanied with its conformational change, which largely weakened the coordination effect between the AFM~1~ aptamer and PdNPs. Thus FAM was separated from PdNPs and the FRET process was blocked. Therefore, the fluorescence recovery of FAM was observed and the degree of fluorescence recovery was in a positive AFM~1~ concentration-dependent manner.

2.2. Properties Characterization of the Energy Acceptor {#sec2dot2-toxins-09-00318}
-------------------------------------------------------

As the 5′-FAM-labeled AFM~1~ aptamer was negatively charged, sodium citrate-modified PdNPs with negative charge were used in this biosensor to avoid the side effect caused by electrostatic attraction which would also bring FAM close to PdNPs. Firstly, 12 nm Pd seeds ([Figure 1](#toxins-09-00318-f001){ref-type="fig"}b) whose light absorption was centered in the ultraviolet region and was very weak in the visible range ([Figure 1](#toxins-09-00318-f001){ref-type="fig"}a) were synthesized using a sodium ascorbate reduction method. Then, larger PdNPs with an average diameter of 33 nm ([Figure 1](#toxins-09-00318-f001){ref-type="fig"}d) were synthesized on the basis of the 12 nm Pd seeds according to a seed-mediated growth method. The UV-Vis absorption spectrum of the 33 nm PdNPs in [Figure 1](#toxins-09-00318-f001){ref-type="fig"}c clearly showed that it exhibited strong absorption in nearly the whole UV-Vis spectral range, which overlaps well with the emission spectrum of FAM, which was essential for FRET occurrence between FAM and PdNPs.

2.3. Construction of the AFM~1~ Aptasensor {#sec2dot3-toxins-09-00318}
------------------------------------------

To investigate the energy transfer efficiency between the FAM donor and PdNPs acceptor pair, an increasing concentration of 33 nm PdNPs were added into a fixed amount of 5′-FAM-labeled AFM~1~ aptamer (80 nM). After incubation in HEPES buffer (20 mM, pH = 7.0) containing 5 mM KCl and 5 mM MgCl~2~ for a short while, a PdNPs concentration-dependent fluorescence quenching phenomenon of 5′-FAM-labeled AFM~1~ aptamer was observed with the maximum quenching efficiency reaching 95%, as indicated in [Figure 2](#toxins-09-00318-f002){ref-type="fig"}a. In order to investigate the non-specific fluorescence quenching caused by PdNPs towards fluorescein dye, fluorescein dye at a final concentration of 80 nM was mixed with PdNPs (0.060 mg/mL) in HEPES buffer for 1 h and then the fluorescence intensity of fluorescein was measured. From [Figure 2](#toxins-09-00318-f002){ref-type="fig"}b it clearly indicated that the non-specific fluorescence quenching caused by PdNPs towards fluorescein could be eliminated. Therefore, the effective fluorescence quenching of FAM caused by PdNPs was ascribed to the strong coordination effect between nitrogen functional groups of the AFM~1~ aptamer and PdNPs, which brought FAM close to PdNPs resulting the occurrence of FRET. The time dependence of fluorescence quenching efficiency indicated in [Figure 2](#toxins-09-00318-f002){ref-type="fig"}c suggested that it only took 30 min to reach the quenching equilibrium. In the following fluorescence recovery experiments, In order to ensure reaching the quenching equilibrium and obtain stable fluorescence signal, 1 h incubation time was chosen for the fluorescence quenching experiment.

2.4. AFM~1~ Detection in Aqueous Buffer Solution {#sec2dot4-toxins-09-00318}
------------------------------------------------

As illustrated in [Scheme 1](#toxins-09-00318-sch001){ref-type="scheme"}, after AFM~1~ was introduced into the 5′-FAM-AFM~1~ aptamer-PdNPs FRET system in the HEPES buffer, the AFM~1~ aptamer preferentially bound to AFM~1~ accompanied by its conformational change, which greatly weakened the coordination effect between the AFM~1~ aptamer and PdNPs. Therefore, FAM was separated from PdNPs and the FRET process was inhibited. Meanwhile, the fluorescence of FAM was restored and the degree of fluorescence recovery was in an AFM~1~ concentration-dependent manner, as indicated in [Figure 3](#toxins-09-00318-f003){ref-type="fig"}a. A linear relationship between the fluorescence recovery of FAM and the concentration of AFM~1~ in the range from 5 pg/mL to 150 pg/mL was obtained in the HEPES buffer, with the detection limit of 1.5 pg/mL (calculated as the concentration corresponding to three times of the standard deviation of the background signal from seven independent measurements) ([Figure 3](#toxins-09-00318-f003){ref-type="fig"}b). Compared to the previously reported structure, switching aptamer-based FRET assay for AFM~1~ detection with a linear detection range from 25 ng/kg to 2000 ng/kg \[[@B25-toxins-09-00318]\], and the time-resolved fluorescent competitive immunochromatographic assay for AFM~1~ detection in milk with a linear dynamic range of 0.1--2.0 ng/mL \[[@B34-toxins-09-00318]\], the sensitivity of the present sensor is significantly improved, which shows great potential to detect lower concentration of AFM~1~ in milk samples. The performance improvement of this FRET largely relied on the excellent fluorescence quenching ability of PdNPs towards FAM, with almost negligible non-specific fluorescence quenching. Other interfering toxins, including AFB~1~, OTA, ZEN, FB~1~ and *T*-2 toxin, were added individually into the FAM-AFM~1~ aptamer-PdNPs FRET system in the place of AFM~1~ under the same experimental procedures to examine the specificity of this FRET biosensor for AFM~1~. It can be seen from [Figure 4](#toxins-09-00318-f004){ref-type="fig"} that the interference toxins all cause negligible fluorescence variation of FAM compared to AFM~1~, which firmly indicated the excellent specificity of this developed FRET biosensor towards AFM~1~ as a result of the high binding affinity between AFM~1~ aptamer and AFM~1~.

2.5. AFM~1~ Detection in Milk Samples {#sec2dot5-toxins-09-00318}
-------------------------------------

In order to ensure consumption safety and human health, it is very important to monitor the concentration of AFM~1~ in milk. In this paper, AFM~1~ detection was also realized in 100-fold diluted milk sample with HEPES buffer under the same experimental procedures as that in the aqueous buffer solution. It can be seen from [Figure 5](#toxins-09-00318-f005){ref-type="fig"}a that the fluorescence of FAM was restored in a AFM~1~ concentration-dependent manner. And the degree of fluorescence restoration was linear related to the concentration of AFM~1~ in the range from 6 pg/mL to 150 pg/mL, with a detection limit of 1.8 pg/mL (calculated as the concentration corresponding to three times of the standard deviation of the background signal from seven independent measurements) ([Figure 5](#toxins-09-00318-f005){ref-type="fig"}b). The relatively narrower linear range and higher detection limit may be ascribed to the complexity of the milk sample. Standard addition experiments were conducted to examine the feasibility of this AFM~1~ biosensor in practical AFM~1~-free milk samples. The satisfactory recoveries from 92% to 106.5% in [Table 1](#toxins-09-00318-t001){ref-type="table"} convincingly demonstrates that this FRET biosensor based on the efficient fluorescence resonance energy transfer between FAM and PdNPs has great potential in practical application.

3. Conclusions {#sec3-toxins-09-00318}
==============

In summary, a highly sensitive FRET aptasensor for AFM~1~ detection has been constructed based on the excellent fluorescence quenching ability of PdNPs towards FAM with negligible non-specific fluorescence quenching. The application of AFM~1~ aptamer with high affinity and specificity towards AFM~1~ also contributes to the good performance of this biosensor in both aqueous buffer solution and milk samples. In consideration of its simple configuration and operation, the homogeneous FRET aptasensor can be widely used to detect a variety of food contaminants, such as other biotoxins in the future.

4. Materials and Methods {#sec4-toxins-09-00318}
========================

4.1. Materials {#sec4dot1-toxins-09-00318}
--------------

Standard solutions of AFM~1~, AFB~1~, ochratoxin A (OTA), zearalenone (ZEN), fumonisin B~1~ (FB~1~) and *T*-2 toxin were purchased from Sigma-Aldrich (St. Louis, MO, USA). 5′-FAM-labeled AFM~1~ aptamer (5′-FAM-ACTGCTAGAGATTTTCCACAT-3′) was provided by Sangon Biotechnology Co., Ltd. (Shanghai, China). The other reagents were all from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China). The solvents and reagents were used as received without further purification. All aqueous solutions were prepared in ultrapure water obtained from a Milli-Q purification system (Millipore, Kankakee, IL, USA).

4.2. Instrumentation {#sec4dot2-toxins-09-00318}
--------------------

The size and morphology of palladium seeds and larger PdNPs were characterized by a FEI Tecnai G2 F30 transmission electron microscope with an acceleration voltage of 200 kV. The UV-vis absorption measurements were conducted on a Thermo-Spectronic Unicam UV500 spectrometer (Thermo Spectronic, Waltham, MA, USA). The fluorescence spectra were recorded on a HITACHI F-4500 fluorescence spectrometer (HITACHI, Tokyo, Japan).

4.3. Synthesis of Sodium Citrate Capped Palladium Seeds {#sec4dot3-toxins-09-00318}
-------------------------------------------------------

Palladium seeds were synthesized according to a reported procedure \[[@B35-toxins-09-00318]\]. 20% freshly prepared aqueous solutions of sodium citrate (100 µL) and 1% Na~2~PdCl~4~ in water (735 µL) were both added into 47 mL ultrapure water. After the solution was heated to boiling, 0.1% hot sodium ascorbate (2.5 mL) was introduced quickly into the mixture. Boiling under reflux was continued for another 30 min. Then the solution was cooled down to room temperature naturally and filtered through a 0.22 um Millipore membrane filter.

4.4. The Synthesis of 33 nm PdNPs {#sec4dot4-toxins-09-00318}
---------------------------------

The synthesis of 33 nm PdNPs was accomplished by a seed-mediated growth method reported by Lu et al. \[[@B36-toxins-09-00318]\]. 10 mL aqueous solution of H~2~PdCl~4~ with a concentration of 1 mM was placed in a 50 mL round-bottom flask. And 3 mL of the synthesized palladium seeds were added. Then an excess amount of aqueous solution of ascorbic acid (100 mM, 1.2 mL) was introduced into the above solutions under extensive stirring. The color of the solution readily changed from pale yellow to a dark brown color, which suggested the formation of larger PdNPs. The resultant solution was stirred for another 5 min at room temperature. Next, the obtained PdNPs were centrifuged and washed with ultrapure water for three times. Finally, the products were redispersed in 3 mL of ultrapure water for further use.

4.5. Quenching Measurements {#sec4dot5-toxins-09-00318}
---------------------------

The concentration of PdNPs used in the FRET system were optimized against a fixed concentration of 5′-FAM-labeled AFM~1~ aptamer, that is, 80 nM. For optimization, the concentrations of PdNPs were set at 0, 0.015 mg/mL, 0.030 mg/mL, 0.045 mg/mL, 0.060 mg/mL, 0.075 mg/mL, 0.090 mg/mL. They were incubated in HEPES buffer (20 mM, pH = 7.0) containing 5 mM KCl and 5 mM MgCl~2~ for 1 h and then the fluorescence intensities were recorded under excitation at 480 nm and emission at 520 nm. The time-dependent fluorescence intensities were obtained by incubating a fixed concentration of 5′-FAM-labeled AFM1 aptamer (80 nM) with PdNPs in a concentration of 0.060 mg/mL from 1 min to 60 min.

4.6. AFM~1~ Detection in Aqueous Buffer Solution {#sec4dot6-toxins-09-00318}
------------------------------------------------

In a typical FRET analysis process, various concentrations of AFM~1~ (0, 5 pg/mL, 20 pg/mL, 40 pg/mL, 80 pg/mL, 100 pg/mL, 150 pg/mL, 300 pg/mL, 600 pg/mL, 900 pg/mL, 1200 pg/mL) were first mixed with the 5′-FAM-labeled AFM~1~ aptamer (80 nM) in HEPES buffer, respectively, and the mixtures were all incubated at room temperature for 2 h. Afterwards PdNPs was added individually into the above mixtures with an ultimate concentration of 0.060 mg/mL, followed by incubation for another 1 h at room temperature. Finally, the fluorescence intensity of the reaction mixture was recorded under excitation at 480 nm and emission at 520 nm. To examine the specificity of the FRET aptasensor, a list of other mycotoxins including AFB~1~, OTA, ZEN, FB~1~ and *T*-2 toxin were added into the FAM-AFM~1~ aptamer-PdNPs FRET system in place of AFM~1~ following the same experimental procedures.

4.7. AFM~1~ Detection in Milk Samples {#sec4dot7-toxins-09-00318}
-------------------------------------

The milk samples (7% fat content) were purchased from the local market of Wuhan, China. They were first centrifuged at 5000 rpm for 10 min at 25 °C to remove the fat and the supernatant were collected respectively. For the determination of AFM~1~ in milk samples, the supernatant was 100-fold diluted with HEPES buffer without further processing, and the same assay procedure as in the HEPES buffer solution was followed. Standard addition method was adopted to determine the concentration of AFM~1~ in AFM~1~-free milk samples.
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Figures, Scheme and Table
=========================

![Schematic illustration of the biosensor for aflatoxin M~1~ (AFM~1~) detection based on aptamer-bridged fluorescence resonance energy transfer (FRET) from 5-carboxyfluorescein (FAM) to palladium nanoparticles (PdNPs).](toxins-09-00318-sch001){#toxins-09-00318-sch001}

![(**a**) Ultraviolet-visible (UV/Vis) absorption spectra of the 12 nm PdNPs; (**b**) transmission electron microscope (TEM) images of the 12 nm PdNPs; (**c**) UV/Vis absorption spectra of the 33 nm PdNPs; (**d**) TEM images of the 33 nm PdNPs.](toxins-09-00318-g001){#toxins-09-00318-f001}

![(**a**) Fluorescence quenching of 5′-FAM-labeled AFM~1~ aptamer after incubated with different concentrations of 33 nm PdNPs (0, 0.015 mg/mL, 0.030 mg/mL, 0.045 mg/mL, 0.060 mg/mL, 0.075 mg/mL, 0.090 mg/mL). (**b**) Fluorescence quenching of fluorescein in the presence of 0.060 mg/mL PdNPs (33 nm). (**c**) Time dependence of the fluorescence quenching degree for 80 nM 5′-FAM-labeled AFM~1~ aptamer caused by 0.060 mg/mL PdNPs (33 nm). All experiments were performed in HEPES buffer under excitation at 480 nm and emission at 520 nm.](toxins-09-00318-g002){#toxins-09-00318-f002}

![(**a**) The fluorescence recovery trend line in accordance with different concentrations of AFM~1~ (5, 20, 40, 80, 100, 150, 300, 600, 900, 1200 pg/mL). *F*~0~ represents the fluorescence intensity in the absence of AFM~1~. (**b**) The linear relationship between the fluorescence recovery degree (at 520 nm) and the concentration of AFM~1~ within the range from 5 pg/mL to 150 pg/mL, data were presented as average ± SD from three independent measurements. Experiments were conducted in the presence of 80 nM 5′-FAM-labeled AFM~1~ aptamer and 0.060 mg/mL PdNPs in HEPES buffer under excitation at 480 nm.](toxins-09-00318-g003){#toxins-09-00318-f003}

![Relative fluorescence intensity ((*F*~other\ mycotoxins~ − *F*~0~)/(*F*~AFM1~ − *F*~0~)) of the aptamer-bridged FRET biosensor for AFM~1~ detection in the presence of different mycotoxins, where *F*~0~ is the fluorescence intensity in the absence of AFM~1~ or other mycotoxins. Data were presented as average ±SD from three independent measurements. The concentration of mycotoxins were all 150 pg/mL. Experiments were conducted in HEPES buffer under excitation at 480 nm.](toxins-09-00318-g004){#toxins-09-00318-f004}

![(**a**) Fluorescence recovery of the biosensor with the introduction of different amounts of AFM~1~ (6, 30, 60, 90, 120, 150, 300, 600, 900, 1200 pg/mL) in 100-diluted milk sample. (**b**) The linear relationship between the fluorescence recovery (at 520 nm) and the concentration of AFM~1~ within the range of 6--150 pg/mL in diluted milk, data were presented as average ±SD from three independent measurements. All experiments were performed in the presence of 80 nM 5′-FAM-labeled AFM~1~ aptamer and 0.060 mg/mL PdNPs under excitation at 480 nm.](toxins-09-00318-g005){#toxins-09-00318-f005}

toxins-09-00318-t001_Table 1

###### 

Determination of AFM~1~ in three milk samples.

  Sample No.   Added (pg/mL)   Found (pg/mL) ^a^   Recovery (%)   Relative Standard Deviation (RSD) (%) *n* = 3
  ------------ --------------- ------------------- -------------- -----------------------------------------------
  1            10              9.20                92.0           3.4
  2            70              65.64               93.8           4.8
  3            120             127.85              106.5          4.9

^a^ Mean value of three determinations by the aptasensor.
